Natural or Synthetic Therapeutics That Block PAKs

作者: Hiroshi Maruta , Shanta M. Messerli , Ramesh K. Jha

DOI: 10.1016/B978-0-12-407198-8.00003-5

关键词:

摘要: Since the late 1990s, a variety of evidence has accumulated that clearly indicates deregulation PAK1 is responsible for life-threatening diseases and disorders such as cancers. In other words, blockers, either synthetic compounds or natural products, could cure delay these PAK1-dependent disorders. turn this century, blockers have been identified developed, at least few them are already available on market be useful treatment Here we shall introduce several FK228 propolis, which help both clinicians patients who suffer from The major difference conventional chemotherapeutics (chemos) DNA/RNA/microtubule poisons unlike chemos, cause no side effects in patients, simply because not essential growth normal cells. Thus, would suitable even lifelong genetic neurofibromatosis (NF) tuberous sclerosis (TSC), addition to relatively short-term solid tumors gliomas pancreatic, colon, lung

参考文章(101)
A Levitzki, E Manser, H Maruta, H He, L Lim, Y Hirokawa, Signal therapy for RAS-induced cancers in combination of AG 879 and PP1, specific inhibitors for ErbB2 and Src family kinases, that block PAK activation. Cancer Journal. ,vol. 7, pp. 191- 202 ,(2001)
Ghosh Pc, LeQuesne Pw, Larrahondo Je, Raffauf Rf, Antitumor plants. IV. Constituents of Simarouba versicolor. Lloydia. ,vol. 40, pp. 364- 369 ,(1977)
F A Valeriote, E D Moher, T H Corbett, J L Collins, T J Fleck, P A Grieco, Anticancer activity of glaucarubinone analogues. Oncology Research. ,vol. 10, pp. 201- 208 ,(1998)
H. Maruta, Anjali Tikoo, M. Varga, Vijaya Ramesh, J. Gusella, An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). Journal of Biological Chemistry. ,vol. 269, pp. 23387- 23390 ,(1994) , 10.1016/S0021-9258(17)31525-9
Anna C. Maroney, Marcie A. Glicksman, Alie N. Basma, Kevin M. Walton, Ernest Knight, Carol A. Murphy, Becky A. Bartlett, James P. Finn, Thelma Angeles, Yuzuru Matsuda, Nicola T. Neff, Craig A. Dionne, Motoneuron Apoptosis Is Blocked by CEP-1347 (KT 7515), a Novel Inhibitor of the JNK Signaling Pathway The Journal of Neuroscience. ,vol. 18, pp. 104- 111 ,(1998) , 10.1523/JNEUROSCI.18-01-00104.1998
Audrey Sicard, Jean-Philippe Semblat, Caroline Doerig, Romain Hamelin, Marc Moniatte, Dominique Dorin-Semblat, Julie A. Spicer, Anubhav Srivastava, Silke Retzlaff, Volker Heussler, Andrew P. Waters, Christian Doerig, Activation of a PAK-MEK signalling pathway in malaria parasite-infected erythrocytes Cellular Microbiology. ,vol. 13, pp. 836- 845 ,(2011) , 10.1111/J.1462-5822.2011.01582.X
Satoshi Õmura, Andy Crump, The life and times of ivermectin — a success story Nature Reviews Microbiology. ,vol. 2, pp. 984- 989 ,(2004) , 10.1038/NRMICRO1048
M.S. Nur-E-Kamal, M Varga, H Maruta, The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype. Journal of Biological Chemistry. ,vol. 268, pp. 22331- 22337 ,(1993) , 10.1016/S0021-9258(18)41532-3
Lan Li, Fadi S. Braiteh, Razelle Kurzrock, Liposome-encapsulated curcumin Cancer. ,vol. 104, pp. 1322- 1331 ,(2005) , 10.1002/CNCR.21300
Gabriel N. Hortobagyi, Mien Chie Hung, Weiya Xia, Lisha Zhang, Yiu Keung Lau, Tyrosine Kinase Inhibitor Emodin Suppresses Growth of HER-2/neu-overexpressing Breast Cancer Cells in Athymic Mice and Sensitizes These Cells to the Inhibitory Effect of Paclitaxel Clinical Cancer Research. ,vol. 5, pp. 343- 353 ,(1999)